Advertisement
For patients with stage III melanoma with BRAF V600E or V600K mutations

Benefit of Adjuvant Dabrafenib + Trametinib Persists in Melanoma

0
Long-term benefit seen for relapse-free survival in stage III disease with BRAF V600E, V600K mutations
Just over 54 percent of Americans now say they would get a COVID-19 vaccine in the first 12 months after it is introduced

Poll: Americans Now More Likely to Get COVID-19 Vaccine

0
However, only 27 percent said they would get a vaccine within the first three months of it being available
For children with type 1 diabetes

Closed-Loop System Beneficial for Children With T1DM

0
Glucose level within target range for greater percentage of time than with sensor-augmented insulin pump
For patients with amyotrophic lateral sclerosis

Sodium Phenylbutyrate-Taurursodiol Promising for ALS

0
Slower functional decline seen with active drug versus placebo through 24 weeks
For the second time in days

John Wagner No Longer Heading FDA Office of External Affairs

0
Departure comes after mishandling of an announcement about experimental therapy for COVID-19
Among patients with heart failure

Empagliflozin Superior to Placebo for Heart Failure

0
Risk for CV death, hospitalization with heart failure reduced, regardless of presence of diabetes
The COVID-19 pandemic in Philadelphia has brought changes in pediatric asthma care delivery patterns

Pandemic Changed Asthma Care Delivery for Children

0
Simultaneously, admissions and systemic steroid prescriptions also declined
In a synopsis of the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense clinical practice guideline

VA/DoD Issue Guideline for Diagnosis, Management of HTN

0
Measurement of BP; target treatment goals; nonpharmacologic, pharmacologic therapy discussed
Higher serum 25-hydroxyvitamin D concentrations are associated with a lower risk for incident type 2 diabetes

Higher Vitamin D Levels Linked to Lower Risk for Type 2 Diabetes

0
Relationship modified by overall sleep patterns, especially with daytime sleepiness
The United States will not join an international effort to create and distribute a COVID-19 vaccine

U.S. Will Not Join International COVID-19 Vaccine Effort

0
White House says it does not want to be constrained by multinational groups such as the WHO